Lantern Pharma Inc. (LTRN) Social Stream
Lantern Pharma Inc (LTRN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LTRN.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 32 weeks, LTRN's average price target has gone up $2.33.
LTRN reports an average of 156.8% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
LTRN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 120 days, LTRN's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Lantern Pharma Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 14.01% of that group.
- In the context of all US stocks, Lantern Pharma Inc's upside potential (average analyst target price relative to current price) is greater than 280.8% of them.
- LTRN has a higher average analyst price target than 274.76% of stocks in the micro market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Lantern Pharma Inc's variance in analysts' estimates is lower than 35.96% of them.
What is the outlook for LTRN? Use POWR Ratings for clearer insight into price direction.